Mark Opdam

Mark Opdam


+31 20 512 2004 Sabine Linn

In 2010, I started in the AVL with my three main projects being all about breast cancer:

  1. MATADOR project: predicting which breast cancer patients have more benefit of taxanes and which of dose dense anthracyclines
  2. N4+ High dose project, including the development of a digital MLPA BRCA1/2 test.
  3. IKA tamoxifen-project with endocrine treated and untreated postmenopausal patients in which we try to find a group that do extremely well without tamoxifen and a group that has a bad survival independent of tamoxifen treatment.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.